RecruitingAsthma in ChildrenAsthma Attack
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
Eligible age
5–17 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.
Sponsor: University of Oklahoma
You may qualify if…
- ✓ Ages 5-17 years old
- ✓ Presents to the ED with a respiratory score in the "Moderate" range (6
- ✓ Parent(s)/Caregiver(s) speak English
You may not qualify if…
- ✕ Patients with chronic medical conditions including chronic pulmonary disease (other than asthma), cerebral palsy, congenital heart disease, tracheostomy dependent, myasthenia gravis patients
- ✕ Patients who are pregnant
- ✕ Parent(s)/Caregiver(s) do not speak English
Where it's recruiting
Oklahoma
Oklahoma City
Source: ClinicalTrials.gov · NCT06137040 · last updated 2024-12-06